Intra-individual comparison of F-FDOPA and Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.
Fiche publication
Date publication
août 2020
Journal
Clinical endocrinology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe, Pr KARCHER Gilles, Pr IMPERIALE Alessio
Tous les auteurs :
Ouvrard E, Chevalier E, Addeo P, Sahakian N, Detour J, Goichot B, Bachellier P, Karcher G, Taïeb D, Imperiale A
Lien Pubmed
Résumé
In patients with ileal neuroendocrine tumours (ileal-NETs), head-to-head evaluation of diagnostic performances of Ga-DOTA-peptides and F-fluorodihydroxyphenylalanine ( F-FDOPA) positron emission tomography/computed tomography (PET/CT) has been performed in only few small patients' cohorts. The aim of this retrospective study was to compare Ga-DOTATOC and F-FDOPA PET/CT for metastatic disease assessment in a homogeneous large series of patients with well-differentiated ileal-NETs.
Mots clés
18F-FDOPA, 68Ga-DOTATOC, carcinoid, neuroendocrine tumours, small-intestine
Référence
Clin. Endocrinol. (Oxf). 2020 Aug 13;: